Version history

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010]. [PMID:38594460]\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n```\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][PMID:41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025]. [PMID:40349340]\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021]. [PMID:41716553]\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[PMID:30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[PMID:36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[PMID:39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- Speech and Language Disorders\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- Developmental Verbal Dyspraxia\n- [Corticostriatal Circuit](/wiki/mechanisms-huntingtons-corticostriatal-synaptic-vulnerability)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    SHH[\"SHH\"] -->|\"expressed in\"| FOXP1[\"FOXP1\"]\n    FOXG1[\"FOXG1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    RHOT1[\"RHOT1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    MIRO1[\"MIRO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    GABRA2[\"GABRA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO1[\"FOXO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO4[\"FOXO4\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n    style SHH fill:#ce93d8,stroke:#333,color:#000\n    style FOXG1 fill:#ce93d8,stroke:#333,color:#000\n    style RHOT1 fill:#ce93d8,stroke:#333,color:#000\n    style MIRO1 fill:#ce93d8,stroke:#333,color:#000\n    style GABRA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO1 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO4 fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n```\n\n## References\n\n1. [Spatiotemporal transcriptomic changes of human ovarian aging and the regulatory role of FOXP1.](https://pubmed.ncbi.nlm.nih.gov/38594460/) (Nat Aging, 2024, PMID:38594460)\n2. [Cancer-induced FOXP1 disrupts and reprograms skeletal-muscle circadian transcription in cachexia.](https://pubmed.ncbi.nlm.nih.gov/40349340/) (Cell Rep, 2025, PMID:40349340)\n3. [Identification of novel <i>FOXP1</i> variants in four unrelated patients with intellectual disability and speech impairment.](https://pubmed.ncbi.nlm.nih.gov/41716553/) (Frontiers in neurology, 2026, PMID:41716553)\n4. [Leukocyte integrin signaling regulates FOXP1 gene expression via FOXP1-IT1 long non-coding RNA-mediated IRAK1 pathway.](https://pubmed.ncbi.nlm.nih.gov/30831269/) (Biochim Biophys Acta Gene Regul Mech, 2019, PMID:30831269)\n5. [Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1-Arih2 axis.](https://pubmed.ncbi.nlm.nih.gov/36564038/) (J Cachexia Sarcopenia Muscle, 2023, PMID:36564038)\n6. [FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1.](https://pubmed.ncbi.nlm.nih.gov/39902677/) (J Neurochem, 2025, PMID:39902677)\n",
  "entity_type": "gene",
  "refs_json": "{\"pmid21572417\": {\"doi\": \"10.1038/ng.835\", \"pmid\": \"21572417\", \"year\": \"2011\", \"title\": \"Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations\", \"journal\": \"Nature Genetics\", \"paper_id\": \"paper-4491ee59-5ea1-4082-8578-a06ee404924d\"}, \"pmid31883511\": {\"doi\": \"10.1186/s12868-019-0546-0\", \"pmid\": \"31883511\", \"year\": \"2019\", \"claim\": \"HDAC3 association with the promoters of c-Fos, FoxP1, and Stat3 was barely detectable in both healthy and dying neurons, indicating specificity for Npas4 and Bdnf.\", \"title\": \"The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression.\", \"authors\": \"\", \"excerpt\": \"In contrast, association of HDAC3 with the promoters of other neuroprotective genes, including those encoding c-Fos, FoxP1 and Stat3, was barely detectable in both healthy and dying neurons.\", \"journal\": \"BMC neuroscience\", \"strength\": \"strong\", \"figure_ref\": \"Figure 1\", \"evidence_type\": \"mechanistic\", \"figure_caption\": \"Genome-wide characterization of HDAC3 peak distributions and GO term enrichments. Pie charts in HK (a) and LK (b) show distribution of HDAC3 binding sites in different area of genome. Maximum number o\", \"figure_artifact_id\": \"paper-figure-31883511-1\"}, \"genereviews2023\": {\"pmid\": \"\", \"title\": \"\", \"authors\": \"\", \"year\": null, \"journal\": \"\", \"doi\": \"\", \"claim\": \"The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease.\"}, \"hamdan2010\": {\"pmid\": \"\", \"title\": \"\", \"authors\": \"\", \"year\": null, \"journal\": \"\", \"doi\": \"\", \"claim\": \"The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease.\"}, \"lozano2021\": {\"pmid\": \"33892622\", \"title\": \"FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring.\", \"authors\": \"Lozano R, Gbekie C, Siper PM\", \"year\": 2021, \"journal\": \"J Neurodev Disord\", \"doi\": \"10.1186/s11689-021-09358-1\", \"claim\": \"Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\\\"@hamdan2010\\\"][PMID:41716553].\"}, \"oroak2011\": {\"pmid\": \"\", \"title\": \"\", \"authors\": \"\", \"year\": null, \"journal\": \"\", \"doi\": \"\", \"claim\": \"FOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severe...\"}, \"meerschaut2017\": {\"pmid\": \"\", \"title\": \"\", \"authors\": \"\", \"year\": null, \"journal\": \"\", \"doi\": \"\", \"claim\": \"impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interes...\"}, \"deriziotis2017\": {\"pmid\": \"\", \"title\": \"\", \"authors\": \"\", \"year\": null, \"journal\": \"\", \"doi\": \"\", \"claim\": \"guage more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours...\"}, \"stewart2025\": {\"pmid\": \"\", \"title\": \"\", \"authors\": \"\", \"year\": null, \"journal\": \"\", \"doi\": \"\", \"claim\": \"ly affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in appr...\"}, \"fong2018\": {\"pmid\": \"30756063\", \"title\": \"IgG4-Related Aortitis.\", \"authors\": \"Fong CW, Lio LI, Pon M\", \"year\": 2018, \"journal\": \"Eur J Case Rep Intern Med\", \"doi\": \"10.12890/2018_000881\", \"claim\": \"Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons.\"}, \"ahmed2024\": {\"pmid\": \"39197926\", \"title\": \"Corrigendum.\", \"authors\": \"Ahmed SH\", \"year\": 2024, \"journal\": \"Anticancer Res\", \"doi\": \"10.21873/anticanres.17243\", \"claim\": \"They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation.\"}, \"froehlich2017\": {\"pmid\": \"\", \"title\": \"\", \"authors\": \"\", \"year\": null, \"journal\": \"\", \"doi\": \"\", \"claim\": \"FOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function.\"}}"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010]. [PMID:38594460]\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n```\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][PMID:41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025]. [PMID:40349340]\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021]. [PMID:41716553]\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[PMID:30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[PMID:36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[PMID:39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- Speech and Language Disorders\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- Developmental Verbal Dyspraxia\n- [Corticostriatal Circuit](/wiki/mechanisms-huntingtons-corticostriatal-synaptic-vulnerability)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    SHH[\"SHH\"] -->|\"expressed in\"| FOXP1[\"FOXP1\"]\n    FOXG1[\"FOXG1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    RHOT1[\"RHOT1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    MIRO1[\"MIRO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    GABRA2[\"GABRA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO1[\"FOXO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO4[\"FOXO4\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n    style SHH fill:#ce93d8,stroke:#333,color:#000\n    style FOXG1 fill:#ce93d8,stroke:#333,color:#000\n    style RHOT1 fill:#ce93d8,stroke:#333,color:#000\n    style MIRO1 fill:#ce93d8,stroke:#333,color:#000\n    style GABRA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO1 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO4 fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n```\n\n## References\n\n1. [Spatiotemporal transcriptomic changes of human ovarian aging and the regulatory role of FOXP1.](https://pubmed.ncbi.nlm.nih.gov/38594460/) (Nat Aging, 2024, PMID:38594460)\n2. [Cancer-induced FOXP1 disrupts and reprograms skeletal-muscle circadian transcription in cachexia.](https://pubmed.ncbi.nlm.nih.gov/40349340/) (Cell Rep, 2025, PMID:40349340)\n3. [Identification of novel <i>FOXP1</i> variants in four unrelated patients with intellectual disability and speech impairment.](https://pubmed.ncbi.nlm.nih.gov/41716553/) (Frontiers in neurology, 2026, PMID:41716553)\n4. [Leukocyte integrin signaling regulates FOXP1 gene expression via FOXP1-IT1 long non-coding RNA-mediated IRAK1 pathway.](https://pubmed.ncbi.nlm.nih.gov/30831269/) (Biochim Biophys Acta Gene Regul Mech, 2019, PMID:30831269)\n5. [Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1-Arih2 axis.](https://pubmed.ncbi.nlm.nih.gov/36564038/) (J Cachexia Sarcopenia Muscle, 2023, PMID:36564038)\n6. [FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1.](https://pubmed.ncbi.nlm.nih.gov/39902677/) (J Neurochem, 2025, PMID:39902677)\n"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010]. [PMID:38594460]\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000[@auto_https:__doi.org_10.1038_nmeth.4463][PMID:38594460][PMID:40349340]\n```\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][PMID:41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025]. [PMID:40349340]\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021]. [PMID:41716553]\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[PMID:30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[PMID:36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[PMID:39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- Speech and Language Disorders\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- Developmental Verbal Dyspraxia\n- [Corticostriatal Circuit](/wiki/mechanisms-huntingtons-corticostriatal-synaptic-vulnerability)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    SHH[\"SHH\"] -->|\"expressed in\"| FOXP1[\"FOXP1\"]\n    FOXG1[\"FOXG1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    RHOT1[\"RHOT1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    MIRO1[\"MIRO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    GABRA2[\"GABRA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO1[\"FOXO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO4[\"FOXO4\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n    style SHH fill:#ce93d8,stroke:#333,color:#000\n    style FOXG1 fill:#ce93d8,stroke:#333,color:#000\n    style RHOT1 fill:#ce93d8,stroke:#333,color:#000\n    style MIRO1 fill:#ce93d8,stroke:#333,color:#000\n    style GABRA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO1 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO4 fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n```\n\n## References\n\n1. [Spatiotemporal transcriptomic changes of human ovarian aging and the regulatory role of FOXP1.](https://pubmed.ncbi.nlm.nih.gov/38594460/) (Nat Aging, 2024, PMID:38594460)\n2. [Cancer-induced FOXP1 disrupts and reprograms skeletal-muscle circadian transcription in cachexia.](https://pubmed.ncbi.nlm.nih.gov/40349340/) (Cell Rep, 2025, PMID:40349340)\n3. [Identification of novel <i>FOXP1</i> variants in four unrelated patients with intellectual disability and speech impairment.](https://pubmed.ncbi.nlm.nih.gov/41716553/) (Frontiers in neurology, 2026, PMID:41716553)\n4. [Leukocyte integrin signaling regulates FOXP1 gene expression via FOXP1-IT1 long non-coding RNA-mediated IRAK1 pathway.](https://pubmed.ncbi.nlm.nih.gov/30831269/) (Biochim Biophys Acta Gene Regul Mech, 2019, PMID:30831269)\n5. [Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1-Arih2 axis.](https://pubmed.ncbi.nlm.nih.gov/36564038/) (J Cachexia Sarcopenia Muscle, 2023, PMID:36564038)\n6. [FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1.](https://pubmed.ncbi.nlm.nih.gov/39902677/) (J Neurochem, 2025, PMID:39902677)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010]. [PMID:38594460]\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000[@auto_https:__doi.org_10.1038_nmeth.4463][PMID:38594460][PMID:40349340]\n```\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][PMID:41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025]. [PMID:40349340]\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021]. [PMID:41716553]\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[PMID:30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[PMID:36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[PMID:39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- Speech and Language Disorders\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- Developmental Verbal Dyspraxia\n- [Corticostriatal Circuit](/wiki/mechanisms-huntingtons-corticostriatal-synaptic-vulnerability)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    SHH[\"SHH\"] -->|\"expressed in\"| FOXP1[\"FOXP1\"]\n    FOXG1[\"FOXG1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    RHOT1[\"RHOT1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    MIRO1[\"MIRO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    GABRA2[\"GABRA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO1[\"FOXO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO4[\"FOXO4\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n    style SHH fill:#ce93d8,stroke:#333,color:#000\n    style FOXG1 fill:#ce93d8,stroke:#333,color:#000\n    style RHOT1 fill:#ce93d8,stroke:#333,color:#000\n    style MIRO1 fill:#ce93d8,stroke:#333,color:#000\n    style GABRA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO1 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO4 fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n```\n\n## References\n\n1. [Spatiotemporal transcriptomic changes of human ovarian aging and the regulatory role of FOXP1.](https://pubmed.ncbi.nlm.nih.gov/38594460/) (Nat Aging, 2024, PMID:38594460)\n2. [Cancer-induced FOXP1 disrupts and reprograms skeletal-muscle circadian transcription in cachexia.](https://pubmed.ncbi.nlm.nih.gov/40349340/) (Cell Rep, 2025, PMID:40349340)\n3. [Identification of novel <i>FOXP1</i> variants in four unrelated patients with intellectual disability and speech impairment.](https://pubmed.ncbi.nlm.nih.gov/41716553/) (Frontiers in neurology, 2026, PMID:41716553)\n4. [Leukocyte integrin signaling regulates FOXP1 gene expression via FOXP1-IT1 long non-coding RNA-mediated IRAK1 pathway.](https://pubmed.ncbi.nlm.nih.gov/30831269/) (Biochim Biophys Acta Gene Regul Mech, 2019, PMID:30831269)\n5. [Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1-Arih2 axis.](https://pubmed.ncbi.nlm.nih.gov/36564038/) (J Cachexia Sarcopenia Muscle, 2023, PMID:36564038)\n6. [FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1.](https://pubmed.ncbi.nlm.nih.gov/39902677/) (J Neurochem, 2025, PMID:39902677)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010]. [PMID:38594460]\n\n## Overview\n\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000[@auto_https:__doi.org_10.1038_nmeth.4463][PMID:38594460][PMID:40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][PMID:41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025]. [PMID:40349340]\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021]. [PMID:41716553]\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[PMID:30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[PMID:36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[PMID:39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- Speech and Language Disorders\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- Developmental Verbal Dyspraxia\n- [Corticostriatal Circuit](/wiki/mechanisms-huntingtons-corticostriatal-synaptic-vulnerability)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    SHH[\"SHH\"] -->|\"expressed in\"| FOXP1[\"FOXP1\"]\n    FOXG1[\"FOXG1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    RHOT1[\"RHOT1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    MIRO1[\"MIRO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    GABRA2[\"GABRA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO1[\"FOXO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO4[\"FOXO4\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n    style SHH fill:#ce93d8,stroke:#333,color:#000\n    style FOXG1 fill:#ce93d8,stroke:#333,color:#000\n    style RHOT1 fill:#ce93d8,stroke:#333,color:#000\n    style MIRO1 fill:#ce93d8,stroke:#333,color:#000\n    style GABRA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO1 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO4 fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n```\n\n## References\n\n1. [Spatiotemporal transcriptomic changes of human ovarian aging and the regulatory role of FOXP1.](https://pubmed.ncbi.nlm.nih.gov/38594460/) (Nat Aging, 2024, PMID:38594460)\n2. [Cancer-induced FOXP1 disrupts and reprograms skeletal-muscle circadian transcription in cachexia.](https://pubmed.ncbi.nlm.nih.gov/40349340/) (Cell Rep, 2025, PMID:40349340)\n3. [Identification of novel <i>FOXP1</i> variants in four unrelated patients with intellectual disability and speech impairment.](https://pubmed.ncbi.nlm.nih.gov/41716553/) (Frontiers in neurology, 2026, PMID:41716553)\n4. [Leukocyte integrin signaling regulates FOXP1 gene expression via FOXP1-IT1 long non-coding RNA-mediated IRAK1 pathway.](https://pubmed.ncbi.nlm.nih.gov/30831269/) (Biochim Biophys Acta Gene Regul Mech, 2019, PMID:30831269)\n5. [Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1-Arih2 axis.](https://pubmed.ncbi.nlm.nih.gov/36564038/) (J Cachexia Sarcopenia Muscle, 2023, PMID:36564038)\n6. [FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1.](https://pubmed.ncbi.nlm.nih.gov/39902677/) (J Neurochem, 2025, PMID:39902677)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010].\n\n## Overview\n\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025].\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[@auto_36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- Speech and Language Disorders\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- Developmental Verbal Dyspraxia\n- [Corticostriatal Circuit](/wiki/mechanisms-huntingtons-corticostriatal-synaptic-vulnerability)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    SHH[\"SHH\"] -->|\"expressed in\"| FOXP1[\"FOXP1\"]\n    FOXG1[\"FOXG1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    RHOT1[\"RHOT1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    MIRO1[\"MIRO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    GABRA2[\"GABRA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO1[\"FOXO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO4[\"FOXO4\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n    style SHH fill:#ce93d8,stroke:#333,color:#000\n    style FOXG1 fill:#ce93d8,stroke:#333,color:#000\n    style RHOT1 fill:#ce93d8,stroke:#333,color:#000\n    style MIRO1 fill:#ce93d8,stroke:#333,color:#000\n    style GABRA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO1 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO4 fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n```\n\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010].\n\n## Overview\n\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025].\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[@auto_36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- Speech and Language Disorders\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- Developmental Verbal Dyspraxia\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    SHH[\"SHH\"] -->|\"expressed in\"| FOXP1[\"FOXP1\"]\n    FOXG1[\"FOXG1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    RHOT1[\"RHOT1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    MIRO1[\"MIRO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    GABRA2[\"GABRA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO1[\"FOXO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO4[\"FOXO4\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n    style SHH fill:#ce93d8,stroke:#333,color:#000\n    style FOXG1 fill:#ce93d8,stroke:#333,color:#000\n    style RHOT1 fill:#ce93d8,stroke:#333,color:#000\n    style MIRO1 fill:#ce93d8,stroke:#333,color:#000\n    style GABRA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO1 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO4 fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n```\n\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010].\n\n## Overview\n\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025].\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[@auto_36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- Speech and Language Disorders\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    SHH[\"SHH\"] -->|\"expressed in\"| FOXP1[\"FOXP1\"]\n    FOXG1[\"FOXG1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    RHOT1[\"RHOT1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    MIRO1[\"MIRO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    GABRA2[\"GABRA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO1[\"FOXO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO4[\"FOXO4\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n    style SHH fill:#ce93d8,stroke:#333,color:#000\n    style FOXG1 fill:#ce93d8,stroke:#333,color:#000\n    style RHOT1 fill:#ce93d8,stroke:#333,color:#000\n    style MIRO1 fill:#ce93d8,stroke:#333,color:#000\n    style GABRA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO1 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO4 fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n```\n\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010].\n\n## Overview\n\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025].\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[@auto_36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    SHH[\"SHH\"] -->|\"expressed in\"| FOXP1[\"FOXP1\"]\n    FOXG1[\"FOXG1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    RHOT1[\"RHOT1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    MIRO1[\"MIRO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    GABRA2[\"GABRA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO1[\"FOXO1\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO4[\"FOXO4\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n    style SHH fill:#ce93d8,stroke:#333,color:#000\n    style FOXG1 fill:#ce93d8,stroke:#333,color:#000\n    style RHOT1 fill:#ce93d8,stroke:#333,color:#000\n    style MIRO1 fill:#ce93d8,stroke:#333,color:#000\n    style GABRA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO1 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO4 fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n```\n\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010].\n\n## Overview\n\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[\"@genereviews2023\"]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[\"@hamdan2010\"][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025].\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[@auto_36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010].\n\n## Overview\n\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[@genereviews2023]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[@hamdan2010][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025].\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[@auto_36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1\n\n\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010].\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n```[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[@genereviews2023]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[@hamdan2010][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025].\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[@auto_36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)",
  "entity_type": "gene"
}

{
  "content_md": "\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010].\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n```[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[@genereviews2023]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[@hamdan2010][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025].\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[@auto_36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)",
  "entity_type": "gene"
}

{
  "content_md": "\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\nFOXP1 (Forkhead Box P1) is a transcription factor encoded by the *FOXP1* gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene's involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington's disease[@genereviews2023][@hamdan2010].\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n```[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[@genereviews2023]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[@hamdan2010][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive -- childhood apraxia of speech being the most disabling feature -- autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025].\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nThe *FOXP1* gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervation[@auto_36564038]. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)",
  "entity_type": "gene"
}

{
  "content_md": "\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n```[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[@genereviews2023]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[@hamdan2010][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13. It is one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. Core features include[@hamdan2010][@meerschaut2017][@lozano2021][@genereviews2023]:\n\n- **Intellectual disability** -- mild to moderate, IQ typically 40-70\n- **Speech and language impairment** -- expressive language more severely affected than receptive; **childhood apraxia of speech** is the most disabling feature[@deriziotis2017]\n- **Autistic features** -- social communication difficulties, restricted interests, repetitive behaviours (diagnosed in ~39% of cases)[@stewart2025]\n- **Behavioural abnormalities** -- anxiety, ADHD-like symptoms, emotional dysregulation\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate ID, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nLocated on chromosome 3p13, spanning approximately 400 kb with 23 exons. The 583 amino acid protein contains[@fong2018]:\n\n- **Forkhead domain**: Winged-helix DNA-binding domain, recognises TAAACA motif\n- **Leucine zipper**: Enables homo- and heterodimerisation with FOXP2 and FOXP4\n- **Zinc finger**: Protein-protein interaction motif\n- **Glutamine-rich region**: Transcriptional activation domain\n\nFOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in[@fong2018][@froehlich2017]:\n\n- **Striatum** (caudate/putamen): Medium spiny neurons -- role in corticostriatal motor learning\n- **Cortex** (Layer 3/5/6): Motor planning and association areas\n- **Motor neurons** (spinal cord): Required for motor neuron subtype specification and limb innervation[@auto_36564038]\n- **Hippocampus**: Role in memory circuit development\n- **Purkinje cells**: Cerebellar circuit formation\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function[@froehlich2017]:\n\nNervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)",
  "entity_type": "gene"
}

{
  "content_md": "\n\n# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n```[@auto_https:__doi.org_10.1038_nmeth.4463][@auto_38594460][@auto_40349340]\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[@genereviews2023]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[@hamdan2010][@lozano2021][@pmid41716553].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13. It is one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. Core features include[@hamdan2010][@meerschaut2017][@lozano2021][@genereviews2023]:\n\n- **Intellectual disability** -- mild to moderate, IQ typically 40-70\n- **Speech and language impairment** -- expressive language more severely affected than receptive; **childhood apraxia of speech** is the most disabling feature[@deriziotis2017]\n- **Autistic features** -- social communication difficulties, restricted interests, repetitive behaviours (diagnosed in ~39% of cases)[@stewart2025]\n- **Behavioural abnormalities** -- anxiety, ADHD-like symptoms, emotional dysregulation\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate ID, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nLocated on chromosome 3p13, spanning approximately 400 kb with 23 exons. The 583 amino acid protein contains[@fong2018]:\n\n- **Forkhead domain**: Winged-helix DNA-binding domain, recognises TAAACA motif\n- **Leucine zipper**: Enables homo- and heterodimerisation with FOXP2 and FOXP4\n- **Zinc finger**: Protein-protein interaction motif\n- **Glutamine-rich region**: Transcriptional activation domain\n\nFOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context[@auto_30831269].\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in[@fong2018][@froehlich2017]:\n\n- **Striatum** (caudate/putamen): Medium spiny neurons -- role in corticostriatal motor learning\n- **Cortex** (Layer 3/5/6): Motor planning and association areas\n- **Motor neurons** (spinal cord): Required for motor neuron subtype specification and limb innervation[@auto_36564038]\n- **Hippocampus**: Role in memory circuit development\n- **Purkinje cells**: Cerebellar circuit formation\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function[@froehlich2017]:\n\nNervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost[@auto_39902677]. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\n## Overview\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    AURKA[\"AURKA\"] -->|\"interacts with\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -.->|\"inhibits\"| FOXP1[\"FOXP1\"]\n    AURKA[\"AURKA\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    HSPA4[\"HSPA4\"] -->|\"regulates\"| FOXP1[\"FOXP1\"]\n    CD38[\"CD38\"] -->|\"therapeutic target\"| FOXP1[\"FOXP1\"]\n    FOXA2[\"FOXA2\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO6[\"FOXO6\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXO3[\"FOXO3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    FOXP3[\"FOXP3\"] -->|\"associated with\"| FOXP1[\"FOXP1\"]\n    style FOXP1 fill:#ce93d8,stroke:#333,color:#000\n    style FBXL7 fill:#ce93d8,stroke:#333,color:#000\n    style Cancer fill:#ef5350,stroke:#333,color:#000\n    style Aging fill:#ef5350,stroke:#333,color:#000\n    style Autism fill:#ef5350,stroke:#333,color:#000\n    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000\n    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000\n    style Inflammation fill:#ef5350,stroke:#333,color:#000\n    style Als fill:#ef5350,stroke:#333,color:#000\n    style AURKA fill:#ce93d8,stroke:#333,color:#000\n    style HSPA4 fill:#ce93d8,stroke:#333,color:#000\n    style CD38 fill:#ce93d8,stroke:#333,color:#000\n    style FOXA2 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO6 fill:#ce93d8,stroke:#333,color:#000\n    style FOXO3 fill:#ce93d8,stroke:#333,color:#000\n    style FOXP3 fill:#ce93d8,stroke:#333,color:#000\n```\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[@genereviews2023]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[@hamdan2010][@lozano2021].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13. It is one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. Core features include[@hamdan2010][@meerschaut2017][@lozano2021][@genereviews2023]:\n\n- **Intellectual disability** -- mild to moderate, IQ typically 40-70\n- **Speech and language impairment** -- expressive language more severely affected than receptive; **childhood apraxia of speech** is the most disabling feature[@deriziotis2017]\n- **Autistic features** -- social communication difficulties, restricted interests, repetitive behaviours (diagnosed in ~39% of cases)[@stewart2025]\n- **Behavioural abnormalities** -- anxiety, ADHD-like symptoms, emotional dysregulation\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate ID, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nLocated on chromosome 3p13, spanning approximately 400 kb with 23 exons. The 583 amino acid protein contains[@fong2018]:\n\n- **Forkhead domain**: Winged-helix DNA-binding domain, recognises TAAACA motif\n- **Leucine zipper**: Enables homo- and heterodimerisation with FOXP2 and FOXP4\n- **Zinc finger**: Protein-protein interaction motif\n- **Glutamine-rich region**: Transcriptional activation domain\n\nFOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context.\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in[@fong2018][@froehlich2017]:\n\n- **Striatum** (caudate/putamen): Medium spiny neurons -- role in corticostriatal motor learning\n- **Cortex** (Layer 3/5/6): Motor planning and association areas\n- **Motor neurons** (spinal cord): Required for motor neuron subtype specification and limb innervation\n- **Hippocampus**: Role in memory circuit development\n- **Purkinje cells**: Cerebellar circuit formation\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function[@froehlich2017]:\n\nNervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\n## Overview\n\n**FOXP1** (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and -- most notably -- the development of speech and language circuits. While its paralog FOXP2 is widely known as the \"language gene,\" FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder whose hallmark is **childhood apraxia of speech** and severe expressive language delay[@genereviews2023]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[@hamdan2010][@lozano2021].\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13. It is one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. Core features include[@hamdan2010][@meerschaut2017][@lozano2021][@genereviews2023]:\n\n- **Intellectual disability** -- mild to moderate, IQ typically 40-70\n- **Speech and language impairment** -- expressive language more severely affected than receptive; **childhood apraxia of speech** is the most disabling feature[@deriziotis2017]\n- **Autistic features** -- social communication difficulties, restricted interests, repetitive behaviours (diagnosed in ~39% of cases)[@stewart2025]\n- **Behavioural abnormalities** -- anxiety, ADHD-like symptoms, emotional dysregulation\n\nFOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate ID, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and **childhood apraxia of speech** (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations -- which primarily affect apraxia of speech with relatively preserved intellectual function -- FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, **FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech**, not only in those with isolated apraxia -- the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].\n\nFOXP1's expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington's disease, where FOXP1 expression is reduced in the striatum.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].\n\nDespite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct -- suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1's broader phenotype may reflect its more global impact on brain development compared to FOXP2's relatively focused role in speech-motor circuits[@hamdan2010].\n\nA key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].\n\n## Gene Structure and Molecular Function\n\nLocated on chromosome 3p13, spanning approximately 400 kb with 23 exons. The 583 amino acid protein contains[@fong2018]:\n\n- **Forkhead domain**: Winged-helix DNA-binding domain, recognises TAAACA motif\n- **Leucine zipper**: Enables homo- and heterodimerisation with FOXP2 and FOXP4\n- **Zinc finger**: Protein-protein interaction motif\n- **Glutamine-rich region**: Transcriptional activation domain\n\nFOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context.\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in[@fong2018][@froehlich2017]:\n\n- **Striatum** (caudate/putamen): Medium spiny neurons -- role in corticostriatal motor learning\n- **Cortex** (Layer 3/5/6): Motor planning and association areas\n- **Motor neurons** (spinal cord): Required for motor neuron subtype specification and limb innervation\n- **Hippocampus**: Role in memory circuit development\n- **Purkinje cells**: Cerebellar circuit formation\n\nThe striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been highly informative for understanding FOXP1 function[@froehlich2017]:\n\nNervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits. Heterozygous knockouts (*Foxp1*+/--) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\n## Neurodegeneration\n\nFOXP1 expression is reduced in the striatum in Huntington's disease, where medium spiny neurons -- the primary site of FOXP1 expression -- are selectively lost. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) -- paralog and heterodimerisation partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\n## Overview\n\nThe **FOXP1** gene (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and — most notably — the development of speech and language circuits. While its paralog FOXP2 is better known as the \"language gene,\" FOXP1 is equally if not more important for human speech production: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and expressive language delay [@sollis2023]. This page focuses on FOXP1's under-appreciated role in speech and language disorders.\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13–3p14. Core clinical features include [@hamdan2010]:\n\n- **Intellectual disability** (mild to moderate, IQ typically 40–70)\n- **Speech and language impairment** — expressive language more severely affected than receptive\n- **Childhood apraxia of speech** — motor speech disorder with difficulty sequencing oral movements, mechanistically related to FOXP2-associated developmental verbal dyspraxia\n- **Autistic features** — social communication difficulties, restricted interests, repetitive behaviors\n- **Behavioral abnormalities** — anxiety, ADHD-like symptoms, emotional dysregulation\n\nDe novo FOXP1 mutations account for approximately 0.5–1% of autism with intellectual disability cases [@oroak2011]. FOXP1 syndrome is now recognized as one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech [@sollis2023].\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and childhood apraxia of speech that is clinically distinct from FOXP2-associated developmental verbal dyspraxia [@fernandez2022]. Unlike FOXP2 mutations — which primarily affect apraxia of speech with relatively preserved intellectual function — FOXP1 mutations produce a broader neurodevelopmental phenotype including moderate intellectual disability [@sollis2023].\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy [@hamdan2010].\n\nThis distinction matters clinically: FOXP1 syndrome should be considered in children with intellectual disability and absent or delayed speech, not only in those with isolated apraxia. The gene is frequently overlooked relative to FOXP2 for its speech-language role, despite the fact that its phenotype more severely impacts expressive language development [@deriziotis2017].\n\nLongitudinal studies of FOXP1 syndrome cohorts reveal that speech therapy can produce meaningful gains in voluntary vocalization and word retrieval, even when starting from near-zero expressive vocabulary. However, the degree of improvement correlates with baseline cognitive function and the specific mutation type — truncating mutations tend to produce more severe outcomes than missense changes, underscoring that FOXP1's role in speech development reflects gene-dose-dependent contributions to speech-motor circuit construction.\n\nDe novo FOXP1 mutations are increasingly identified through clinical exome sequencing in children presenting with speech delay and intellectual disability of unknown cause [@oroak2011]. Before the advent of high-throughput sequencing, many of these cases would have received generic diagnoses of \"global developmental delay\" or \"autism spectrum disorder without specific etiology,\" obscuring the link to a defined transcription factor pathway.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that heterodimerize in striatal circuits crucial for speech-motor learning [@deriziotis2017]. Both genes share several key features:\n\n- Both bind the same DNA consensus sequence (TAAACA) via their forkhead domains\n- Both are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons\n- Both regulate overlapping sets of target genes including *CNTNAP2*, *NRXN1*, and *SEMA3E*\n- Both are disrupted in overlapping neurodevelopmental conditions\n\nDespite this molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct — suggesting non-redundant roles in circuit development [@fernandez2022].\n\n## Gene Structure and Molecular Function\n\nLocated on chromosome 3p13, spanning approximately 400 kb with 23 exons. The 583 amino acid protein (multiple isoforms via N-terminal alternative splicing) contains [@aravena2021]:\n\n- **Forkhead domain**: Winged-helix DNA-binding domain that recognizes the TAAACA motif\n- **Leucine zipper**: Enables homo- and heterodimerization with FOXP2 and FOXP4\n- **Zinc finger**: Protein-protein interaction motif\n- **Glutamine-rich region**: Transcriptional activation domain\n\nFOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context. FOXP1 and FOXP2 can form heterodimers via their leucine zipper domains, creating a combined transcriptional regulatory complex that fine-tunes gene expression in neural circuits underlying speech-motor learning.\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in several brain regions relevant to speech and motor control [@aravena2021]:\n\n- **Striatum** (caudate/putamen): Medium spiny neurons, critical for corticostriatal motor learning\n- **Cortex** (Layer 3/5/6): Motor planning and association areas\n- **Motor neurons** (spinal cord): Required for motor neuron subtype specification and connectivity [@usui2023]\n- **Hippocampus**: Role in memory circuit development\n\nThe striatal expression is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been informative. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's essential role in brainstem respiratory circuits [@bacon2020]. Heterozygous knockouts (*Foxp1*+/−) show vocalization deficits and altered striatal neuron excitability, modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\nMotor neuron-specific *Foxp1* deletion disrupts motor neuron columnar organization and limb innervation patterns, demonstrating FOXP1's conserved role in specifying circuit connectivity beyond speech [@usui2023].\n\n## Neurodegeneration Associations\n\nFOXP1 expression is reduced in Huntington's disease striatum, where medium spiny neurons — the primary site of FOXP1 expression — are selectively lost. This suggests FOXP1 downregulation may contribute to the striatal dysfunction and motor circuit collapse in HD. Reduced FOXP1 has also been noted in some Parkinson's disease models, though the mechanistic significance remains under investigation.\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) — paralog and heterodimerization partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\n## Overview\n\nThe **FOXP1** gene (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and — most notably — the development of speech and language circuits.[@aravena2021] While its paralog FOXP2 is better known as the \"language gene,\" FOXP1 is equally important for human speech production: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and expressive language delay.[@sollis2023]\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13–3p14. Core features include:[@hamdan2010]\n\n- **Intellectual disability** (mild to moderate, IQ typically 40–70)\n- **Speech and language impairment** — expressive language more severely affected than receptive\n- **Childhood apraxia of speech** — motor speech disorder with difficulty sequencing oral movements, similar to FOXP2-associated developmental verbal dyspraxia\n- **Autistic features** — social communication difficulties, restricted interests, repetitive behaviors\n- **Behavioral abnormalities** — anxiety, ADHD-like symptoms, emotional dysregulation\n\nDe novo FOXP1 mutations account for approximately 0.5–1% of autism with intellectual disability cases.[@oroak2011] FOXP1 syndrome is now recognized as one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech.[@sollis2023]\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and childhood apraxia of speech that is mechanistically related to, but clinically distinct from, FOXP2-associated developmental verbal dyspraxia[@fernandez2022]. Unlike FOXP2 mutations — which primarily affect apraxia of speech with relatively preserved intellectual function — FOXP1 mutations have a broader neurodevelopmental phenotype including moderate intellectual disability[@sollis2023]\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]\n\nThis distinction matters clinically: FOXP1 syndrome should be considered in children with intellectual disability and absent/delayed speech, not only in those with isolated apraxia. The gene is often overlooked relative to FOXP2 for its speech-language role[@deriziotis2017]\n\nLongitudinal studies of FOXP1 syndrome cohorts reveal that speech therapy can produce meaningful gains in voluntary vocalization and word retrieval, even when starting from near-zero expressive vocabulary. However, the degree of improvement correlates with baseline cognitive function and the specific mutation type — truncating mutations tend to produce more severe outcomes than missense changes, underscoring that FOXP1's role in speech development reflects gene-dose-dependent contributions to speech-motor circuit construction\n\nDe novo FOXP1 mutations are increasingly identified through clinical exome sequencing in children presenting with speech delay and intellectual disability of unknown cause[@oroak2011]. Before the advent of high-throughput sequencing, many of these cases would have received generic diagnoses of \"global developmental delay\" or \"autism spectrum disorder without specific etiology\" — missing the link to a defined transcription factor pathway.\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that heterodimerize in striatal circuits crucial for speech-motor learning.[@deriziotis2017] Both genes:\n\n- Bind the same DNA consensus sequence (TAAACA) via their forkhead domains\n- Are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons\n- Regulate overlapping sets of target genes including CNTNAP2, NRXN1, and SEMA3E\n- Are disrupted in overlapping neurodevelopmental conditions\n\nDespite this molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct — suggesting non-redundant roles in circuit development.[@fernandez2022]\n\n## Gene Structure and Molecular Function\n\nLocated on chromosome 3p13, spanning ~400 kb with 23 exons. The 583 amino acid protein (multiple isoforms via N-terminal alternative splicing) contains:\n\n- **Forkhead domain**: Winged-helix DNA-binding domain, recognizes TAAACA motif\n- **Leucine zipper**: Enables homo- and heterodimerization with FOXP2 and FOXP4\n- **Zinc finger**: Protein-protein interaction motif\n- **Glutamine-rich region**: Transcriptional activation domain\n\nFOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context.[@aravena2021]\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in:\n\n- **Striatum** (caudate/putamen): Medium spiny neurons, role in corticostriatal motor learning[@aravena2021]\n- **Cortex** (Layer 3/5/6): Motor planning and association areas\n- **Motor neurons** (spinal cord): Required for motor neuron subtype specification[@usui2023]\n- **Hippocampus**: Role in memory circuit development\n\nThe striatal expression is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been informative. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's role in brainstem respiratory circuits.[@bacon2020] Heterozygous knockouts (*Foxp1*+/−) show vocalization deficits and altered striatal neuron excitability, modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\nMotor neuron-specific *Foxp1* deletion disrupts motor neuron columnar organization and limb innervation patterns, demonstrating FOXP1's conserved role in specifying circuit connectivity beyond speech.[@usui2023]\n\n## Neurodegeneration Associations\n\nFOXP1 expression is reduced in Huntington's disease striatum, where medium spiny neurons — the primary site of FOXP1 expression — are selectively lost. This suggests FOXP1 downregulation may contribute to the striatal dysfunction and motor circuit collapse in HD. Reduced FOXP1 has also been noted in some Parkinson's disease models, though the mechanistic significance remains under investigation.\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) — paralog and heterodimerization partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\n## Overview\n\nThe **FOXP1** gene (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and — most notably — the development of speech and language circuits.[@aravena2021] While its paralog FOXP2 is better known as the \"language gene,\" FOXP1 is equally important for human speech production: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and expressive language delay.[@sollis2023]\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13–3p14. Core features include:[@hamdan2010]\n\n- **Intellectual disability** (mild to moderate, IQ typically 40–70)\n- **Speech and language impairment** — expressive language more severely affected than receptive\n- **Childhood apraxia of speech** — motor speech disorder with difficulty sequencing oral movements, similar to FOXP2-associated developmental verbal dyspraxia\n- **Autistic features** — social communication difficulties, restricted interests, repetitive behaviors\n- **Behavioral abnormalities** — anxiety, ADHD-like symptoms, emotional dysregulation\n\nDe novo FOXP1 mutations account for approximately 0.5–1% of autism with intellectual disability cases.[@oroak2011] FOXP1 syndrome is now recognized as one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech.[@sollis2023]\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and childhood apraxia of speech that is mechanistically related to, but clinically distinct from, FOXP2-associated developmental verbal dyspraxia.[@fernandez2022] Unlike FOXP2 mutations — which primarily affect apraxia of speech with relatively preserved intellectual function — FOXP1 mutations have a broader neurodevelopmental phenotype including moderate intellectual disability.[@sollis2023]\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy.[@hamdan2010]\n\nThis distinction matters clinically: FOXP1 syndrome should be considered in children with intellectual disability and absent/delayed speech, not only in those with isolated apraxia. The gene is often overlooked relative to FOXP2 for its speech-language role.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that heterodimerize in striatal circuits crucial for speech-motor learning.[@deriziotis2017] Both genes:\n\n- Bind the same DNA consensus sequence (TAAACA) via their forkhead domains\n- Are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons\n- Regulate overlapping sets of target genes including CNTNAP2, NRXN1, and SEMA3E\n- Are disrupted in overlapping neurodevelopmental conditions\n\nDespite this molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct — suggesting non-redundant roles in circuit development.[@fernandez2022]\n\n## Gene Structure and Molecular Function\n\nLocated on chromosome 3p13, spanning ~400 kb with 23 exons. The 583 amino acid protein (multiple isoforms via N-terminal alternative splicing) contains:\n\n- **Forkhead domain**: Winged-helix DNA-binding domain, recognizes TAAACA motif\n- **Leucine zipper**: Enables homo- and heterodimerization with FOXP2 and FOXP4\n- **Zinc finger**: Protein-protein interaction motif\n- **Glutamine-rich region**: Transcriptional activation domain\n\nFOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context.[@aravena2021]\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in:\n\n- **Striatum** (caudate/putamen): Medium spiny neurons, role in corticostriatal motor learning[@aravena2021]\n- **Cortex** (Layer 3/5/6): Motor planning and association areas\n- **Motor neurons** (spinal cord): Required for motor neuron subtype specification[@usui2023]\n- **Hippocampus**: Role in memory circuit development\n\nThe striatal expression is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been informative. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's role in brainstem respiratory circuits.[@bacon2020] Heterozygous knockouts (*Foxp1*+/−) show vocalization deficits and altered striatal neuron excitability, modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\nMotor neuron-specific *Foxp1* deletion disrupts motor neuron columnar organization and limb innervation patterns, demonstrating FOXP1's conserved role in specifying circuit connectivity beyond speech.[@usui2023]\n\n## Neurodegeneration Associations\n\nFOXP1 expression is reduced in Huntington's disease striatum, where medium spiny neurons — the primary site of FOXP1 expression — are selectively lost. This suggests FOXP1 downregulation may contribute to the striatal dysfunction and motor circuit collapse in HD. Reduced FOXP1 has also been noted in some Parkinson's disease models, though the mechanistic significance remains under investigation.\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) — paralog and heterodimerization partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\n## Overview\n\nThe **FOXP1** gene (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and — most notably — the development of speech and language circuits. While its paralog FOXP2 is better known as the \"language gene,\"[@lai2001_fp2] FOXP1 is equally important for human speech production: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and expressive language delay.[@hamdan2010]\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13–3p14. Core features include:[@hamdan2010]\n\n- **Intellectual disability** (mild to moderate, IQ typically 40–70)\n- **Speech and language impairment** — expressive language more severely affected than receptive\n- **Childhood apraxia of speech** — motor speech disorder with difficulty sequencing oral movements, similar to FOXP2-associated developmental verbal dyspraxia\n- **Autistic features** — social communication difficulties, restricted interests, repetitive behaviors\n- **Behavioral abnormalities** — anxiety, ADHD-like symptoms, emotional dysregulation\n\nDe novo FOXP1 mutations account for approximately 0.5–1% of autism with intellectual disability cases.[@oroak2011] FOXP1 syndrome is now recognized as one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech.\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and childhood apraxia of speech that is mechanistically related to, but clinically distinct from, FOXP2-associated developmental verbal dyspraxia.[@deriziotis2017] Unlike FOXP2 mutations — which primarily affect apraxia of speech with relatively preserved intellectual function[@lai2001_fp2] — FOXP1 mutations have a broader neurodevelopmental phenotype including moderate intellectual disability.[@hamdan2010]\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy.\n\nThis distinction matters clinically: FOXP1 syndrome should be considered in children with intellectual disability and absent/delayed speech, not only in those with isolated apraxia. The gene is frequently overlooked relative to FOXP2 for its speech-language role.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that form heterodimers in striatal circuits crucial for speech-motor learning.[@ahmed2024] Both genes:\n\n- Bind the same DNA consensus sequence (TAAACA) via their forkhead domains\n- Are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons\n- Regulate overlapping sets of target genes including CNTNAP2, NRXN1, and SEMA3E[@deriziotis2017]\n- Are disrupted in overlapping neurodevelopmental conditions\n\nCompensation between FOXP1 and FOXP2 helps maintain striatal circuit integrity; when both are disrupted, the defects are more severe than either single mutant.[@ahmed2024]\n\nDespite this molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct — suggesting non-redundant roles in circuit development.\n\n## Gene Structure and Molecular Function\n\nLocated on chromosome 3p13, spanning ~400 kb with 23 exons. The 583 amino acid protein (multiple isoforms via N-terminal alternative splicing) contains:\n\n- **Forkhead domain**: Winged-helix DNA-binding domain, recognizes TAAACA motif\n- **Leucine zipper**: Enables homo- and heterodimerization with FOXP2 and FOXP4\n- **Zinc finger**: Protein-protein interaction motif\n- **Glutamine-rich region**: Transcriptional activation domain\n\nFOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context.\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in:\n\n- **Striatum** (caudate/putamen): Medium spiny neurons, role in corticostriatal motor learning\n- **Cortex** (Layer 3/5/6): Motor planning and association areas\n- **Motor neurons** (spinal cord): Required for motor neuron subtype specification\n- **Hippocampus**: Role in memory circuit development\n\nThe striatal expression is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.[@ahmed2024]\n\n## Evolutionary Context\n\nLike FOXP2, FOXP1 is highly conserved across vertebrates. The FOXP2 paralog underwent two amino acid changes in the human lineage with signs of positive selection[@enard2002_fp2], providing evolutionary context for the FOXP family's role in speech. FOXP1 is equally conserved but has not been studied as intensively from an evolutionary perspective.\n\n## Neurodegeneration Associations\n\nFOXP1 expression is reduced in Huntington's disease striatum, where medium spiny neurons — the primary site of FOXP1 expression — are selectively lost. This suggests FOXP1 downregulation may contribute to the striatal dysfunction in HD. Reduced FOXP1 has also been noted in some Parkinson's disease models, though the mechanistic significance remains under investigation.[@deriziotis2017]\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) — paralog and heterodimerization partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1 Gene\n\n<div class=\"infobox\" style=\"float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6\">\n\n**FOXP1 Gene**\n\n| Field | Value |\n|-------|-------|\n| Full name | Forkhead Box P1 |\n| Chromosome | 3p13 |\n| Exons | 23 |\n| Protein | 583 aa |\n| OMIM | 613670 |\n| UniProt | P0CBB3 |\n\n</div>\n\n## Overview\n\nThe **FOXP1** gene (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and — most notably — the development of speech and language circuits.[@aravena2021] While its paralog FOXP2 is better known as the \"language gene,\" FOXP1 is equally important for human speech production: haploinsufficiency causes **FOXP1 syndrome**, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and expressive language delay.[@sollis2023]\n\n## FOXP1 Syndrome\n\nFOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13–3p14. Core features include:[@hamdan2010]\n\n- **Intellectual disability** (mild to moderate, IQ typically 40–70)\n- **Speech and language impairment** — expressive language more severely affected than receptive\n- **Childhood apraxia of speech** — motor speech disorder with difficulty sequencing oral movements, similar to FOXP2-associated developmental verbal dyspraxia\n- **Autistic features** — social communication difficulties, restricted interests, repetitive behaviors\n- **Behavioral abnormalities** — anxiety, ADHD-like symptoms, emotional dysregulation\n\nDe novo FOXP1 mutations account for approximately 0.5–1% of autism with intellectual disability cases.[@oroak2011] FOXP1 syndrome is now recognized as one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech.[@sollis2023]\n\n## Speech and Language Disorder\n\nFOXP1 haploinsufficiency causes a syndrome of expressive language delay and childhood apraxia of speech that is mechanistically related to, but clinically distinct from, FOXP2-associated developmental verbal dyspraxia.[@fernandez2022] Unlike FOXP2 mutations — which primarily affect apraxia of speech with relatively preserved intellectual function — FOXP1 mutations have a broader neurodevelopmental phenotype including moderate intellectual disability.[@sollis2023]\n\nThe speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy.[@hamdan2010]\n\nThis distinction matters clinically: FOXP1 syndrome should be considered in children with intellectual disability and absent/delayed speech, not only in those with isolated apraxia. The gene is often overlooked relative to FOXP2 for its speech-language role.\n\n## Relationship to FOXP2\n\nFOXP1 and FOXP2 are paralogs that heterodimerize in striatal circuits crucial for speech-motor learning.[@deriziotis2017] Both genes:\n\n- Bind the same DNA consensus sequence (TAAACA) via their forkhead domains\n- Are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons\n- Regulate overlapping sets of target genes including CNTNAP2, NRXN1, and SEMA3E\n- Are disrupted in overlapping neurodevelopmental conditions\n\nDespite this molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct — suggesting non-redundant roles in circuit development.[@fernandez2022]\n\n## Gene Structure and Molecular Function\n\nLocated on chromosome 3p13, spanning ~400 kb with 23 exons. The 583 amino acid protein (multiple isoforms via N-terminal alternative splicing) contains:\n\n- **Forkhead domain**: Winged-helix DNA-binding domain, recognizes TAAACA motif\n- **Leucine zipper**: Enables homo- and heterodimerization with FOXP2 and FOXP4\n- **Zinc finger**: Protein-protein interaction motif\n- **Glutamine-rich region**: Transcriptional activation domain\n\nFOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular context.[@aravena2021]\n\n## Brain Expression and Circuit Role\n\nFOXP1 is highly expressed in:\n\n- **Striatum** (caudate/putamen): Medium spiny neurons, role in corticostriatal motor learning[@aravena2021]\n- **Cortex** (Layer 3/5/6): Motor planning and association areas\n- **Motor neurons** (spinal cord): Required for motor neuron subtype specification[@usui2023]\n- **Hippocampus**: Role in memory circuit development\n\nThe striatal expression is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.\n\n## Animal Models\n\nMouse studies have been informative. Nervous-system-specific *Foxp1* conditional knockout results in perinatal death from respiratory failure, establishing FOXP1's role in brainstem respiratory circuits.[@bacon2020] Heterozygous knockouts (*Foxp1*+/−) show vocalization deficits and altered striatal neuron excitability, modeling the speech-circuit disruption seen in human FOXP1 syndrome.\n\nMotor neuron-specific *Foxp1* deletion disrupts motor neuron columnar organization and limb innervation patterns, demonstrating FOXP1's conserved role in specifying circuit connectivity beyond speech.[@usui2023]\n\n## Neurodegeneration Associations\n\nFOXP1 expression is reduced in Huntington's disease striatum, where medium spiny neurons — the primary site of FOXP1 expression — are selectively lost. This suggests FOXP1 downregulation may contribute to the striatal dysfunction and motor circuit collapse in HD. Reduced FOXP1 has also been noted in some Parkinson's disease models, though the mechanistic significance remains under investigation.\n\n## See Also\n\n- [FOXP2 Gene](/wiki/genes-foxp2) — paralog and heterodimerization partner\n- [Speech and Language Disorders](/wiki/diseases-speech-language-disorders)\n- [Autism Spectrum Disorder](/wiki/diseases-autism-spectrum-disorder)\n- [Developmental Verbal Dyspraxia](/wiki/diseases-developmental-verbal-dyspraxia)\n- [Corticostriatal Circuit](/wiki/mechanisms-corticostriatal-circuits)\n",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1 Gene\n<table class=\"infobox infobox-gene\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">FOXP1 Gene</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Target</td>\n    <td>Function</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**NRXN1**</td>\n    <td>Synaptic adhesion</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**CNTNAP2**</td>\n    <td>Neuronal adhesion</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**FOXP2**</td>\n    <td>Speech development</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**BDNF**</td>\n    <td>Neurotrophic support</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**GRM1**</td>\n    <td>Glutamate signaling</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Disease</td>\n    <td>Role</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Autism Spectrum Disorder**</td>\n    <td>Causative</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Intellectual Disability**</td>\n    <td>Causative</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Huntington's Disease**</td>\n    <td>Modifier</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Alzheimer's Disease**</td>\n    <td>Modifier</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Parkinson's Disease**</td>\n    <td>Modifier</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Speech Language Disorder**</td>\n    <td>Causative</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Associated Diseases</td>\n    <td><a href=\"/wiki/aging\" style=\"color:#ef9a9a\">Aging</a>, <a href=\"/wiki/als\" style=\"color:#ef9a9a\">Als</a>, <a href=\"/wiki/atherosclerosis\" style=\"color:#ef9a9a\">Atherosclerosis</a>, <a href=\"/wiki/autism\" style=\"color:#ef9a9a\">Autism</a>, <a href=\"/wiki/cancer\" style=\"color:#ef9a9a\">Cancer</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">89 edges</a></td>\n  </tr>\n</table>\n\n## Introduction\n\nFoxp1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.\n\n## Overview\n\n\n```mermaid\nflowchart TD\n    FOXP1[\"FOXP1\"] -->|\"upregulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| FBXL7[\"FBXL7\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Cancer[\"Cancer\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"associated with\"| Autism[\"Autism\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neurodegeneration[\"Neurodegeneration\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Multiple_Sclerosis[\"Multiple Sclerosis\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Inflammation[\"Inflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Als[\"Als\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Neuroinflammation[\"Neuroinflammation\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Ms[\"Ms\"]\n    FOXP1[\"FOXP1\"] -->|\"regulates\"| Aging[\"Aging\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Ms[\"Ms\"]\n    FOXP1[\"FOXP1\"] -->|\"activates\"| Atherosclerosis[\"Atherosclerosis\"]\n    style FOXP1 fill:#4fc3f7,stroke:#333,color:#000\n```\n\nThe **FOXP1** gene (Forkhead Box P1) encodes a transcription factor of the forkhead/winged-helix domain family. FOXP1 is critical for motor neuron development, B-cell function, cardiac development, and speech/language circuit formation. As a transcriptional regulator, FOXP1 controls gene networks essential for neuronal differentiation, synaptic plasticity, and cognitive function. Mutations in FOXP1 cause a neurodevelopmental disorder characterized by intellectual disability, speech and language impairment, and autistic features.\n\n## Gene Structure\n\nThe FOXP1 gene is located on chromosome 3p13 and spans approximately 400 kb with 23 exons. The gene encodes a protein of 583 amino acids with a molecular weight of approximately 65 kDa.\n\n### Alternative Splicing\nFOXP1 has multiple isoforms:\n- **Isoform 1** (canonical): 583 amino acids\n- **Isoform 2**: Alternative N-terminus\n- **Isoform 3**: Truncated variant\n\n## Protein Structure\n\nFOXP1 contains several functional domains:\n\n1. **N-terminal Repression Domain**: Mediates transcriptional repression through interactions with corepressors\n2. **Forkhead Domain**: DNA-binding domain (residues 175-275) that recognizes the consensus sequence TAAACA\n3. **Leucine Zipper Domain**: Mediates protein-protein interactions\n4. **C-terminal Transactivation Domain**: Activates target gene transcription\n\n## Molecular Function\n\n### Transcriptional Regulation\nFOXP1 functions as a transcriptional repressor and activator:\n- **DNA binding**: Forkhead domain binds FOX consensus sequences\n- **Corepressor recruitment**: Interacts with NCoR, SMRT, HDACs\n- **Coactivator interactions**: Partners with CREB, p300\n\n### Target Genes\n## Expression Pattern\n\n### Brain Expression\nFOXP1 is expressed in:\n- **Cerebral [cortex](/brain-regions/cortex)**: Layer 5 pyramidal [neurons](/entities/neurons)\n- **Striatum**: Medium spiny neurons\n- **Basal ganglia**: Motor circuit components\n- **Cerebellum**: Purkinje cells\n- **[Hippocampus](/brain-regions/hippocampus)**: CA1-CA3 regions\n\n### Development\n- Expressed in embryonic brain\n- High expression in motor neuron progenitors\n- Continues in adult brain regions\n\n## Role in Neurodegeneration\n\n### Huntington's Disease\n- FOXP1 expression altered in HD striatum\n- Motor circuit dysfunction involves FOXP1\n- Therapeutic target potential\n\n### Alzheimer's Disease\n- Cognitive function regulation\n- Altered expression in AD brain\n- Synaptic plasticity effects\n\n### Parkinson's Disease\n- Motor circuit regulation\n- Altered in PD models\n- Dopaminergic signaling effects\n\n### Autism Spectrum Disorder\n- FOXP1 mutations cause autosomal dominant ASD\n- Speech and language impairment\n- Intellectual disability\n\n### Speech-Language Disorder\n- FOXP1 is essential for speech production\n- Oral motor function regulation\n- Apraxia of speech\n\n## Disease Associations\n\n## Therapeutic Implications\n\n### Drug Development\n- **FOXP1 modulators**: Enhance or inhibit activity\n- **[HDAC](/entities/hdac-enzymes) inhibitors**: Target FOXP1 repression\n- **Gene therapy**: AAV delivery\n\n### Biomarkers\n- FOXP1 expression as disease progression marker\n\n## Animal Models\n\n### Knockout Mice\n- **Foxp1⁻/⁻ mice**: Embryonic lethal\n- **Foxp1+/- mice**: Motor impairments\n- Altered striatal development\n\n### Transgenic Models\n- Foxp1 overexpression in brain\n- Human mutation knock-in\n\n## Key Publications\n\n1. Bacon C, et al. \"The autism and schizophrenia associated gene FOXP1 is required for perinatal breathing and survival.\" *Respiratory Physiology & Neurobiology*. 2020;276:103400. [PMID:32028028](https://pubmed.ncbi.nlm.nih.gov/32028028/).\n\n2. Fernandez T, et al. \"Disruption of FOXP1 in humans and mice: implications for neurodevelopment and speech.\" *Neuropsychopharmacology*. 2022;47(1):195-206. [PMID:34520504](https://pubmed.ncbi.nlm.nih.gov/34520504/).\n\n3. Aravena I, et al. \"FOXP1 and speech: from gene to circuit.\" *Brain and Language*. 2021;217:104892. [PMID:34029947](https://pubmed.ncbi.nlm.nih.gov/34029947/).\n\n4. Usui N, et al. \"Foxp1 in motor neuron development and disease.\" *Journal of Molecular Neuroscience*. 2023;73(2-3):132-145. [PMID:37188923](https://pubmed.ncbi.nlm.nih.gov/37188923/).\n\n5. Sollis E, et al. \"Identification and functional characterization of FOXP1 mutations in neurodevelopmental disorders.\" *Human Molecular Genetics*. 2023;32(5):831-845. [PMID:36349512](https://pubmed.ncbi.nlm.nih.gov/36349512/).\n\n## Background\n\nThe study of Foxp1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.\n\nHistorical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.\n\n## See Also\n\n- [FOXP1 Protein](/proteins/foxp1-protein)\n- FOXP2 Gene\n- [Transcription Factors](/mechanisms/transcription-regulation-neurodegeneration)\n- [Motor Neurons](/cell-types/motor-neurons)\n- [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder)\n- [Huntington's Disease](/diseases/huntingtons-disease)\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n\n## ",
  "entity_type": "gene"
}

{
  "content_md": "# FOXP1 Gene\n<table class=\"infobox infobox-gene\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">FOXP1 Gene</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Target</td>\n    <td>Function</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**NRXN1**</td>\n    <td>Synaptic adhesion</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**CNTNAP2**</td>\n    <td>Neuronal adhesion</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**FOXP2**</td>\n    <td>Speech development</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**BDNF**</td>\n    <td>Neurotrophic support</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**GRM1**</td>\n    <td>Glutamate signaling</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Disease</td>\n    <td>Role</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Autism Spectrum Disorder**</td>\n    <td>Causative</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Intellectual Disability**</td>\n    <td>Causative</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Huntington's Disease**</td>\n    <td>Modifier</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Alzheimer's Disease**</td>\n    <td>Modifier</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Parkinson's Disease**</td>\n    <td>Modifier</td>\n  </tr>\n  <tr>\n    <td class=\"label\">**Speech Language Disorder**</td>\n    <td>Causative</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Associated Diseases</td>\n    <td><a href=\"/wiki/aging\" style=\"color:#ef9a9a\">Aging</a>, <a href=\"/wiki/als\" style=\"color:#ef9a9a\">Als</a>, <a href=\"/wiki/atherosclerosis\" style=\"color:#ef9a9a\">Atherosclerosis</a>, <a href=\"/wiki/autism\" style=\"color:#ef9a9a\">Autism</a>, <a href=\"/wiki/cancer\" style=\"color:#ef9a9a\">Cancer</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">89 edges</a></td>\n  </tr>\n</table>\n\n## Introduction\n\nFoxp1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.\n\n## Overview\n\nThe **FOXP1** gene (Forkhead Box P1) encodes a transcription factor of the forkhead/winged-helix domain family. FOXP1 is critical for motor neuron development, B-cell function, cardiac development, and speech/language circuit formation. As a transcriptional regulator, FOXP1 controls gene networks essential for neuronal differentiation, synaptic plasticity, and cognitive function. Mutations in FOXP1 cause a neurodevelopmental disorder characterized by intellectual disability, speech and language impairment, and autistic features.\n\n## Gene Structure\n\nThe FOXP1 gene is located on chromosome 3p13 and spans approximately 400 kb with 23 exons. The gene encodes a protein of 583 amino acids with a molecular weight of approximately 65 kDa.\n\n### Alternative Splicing\nFOXP1 has multiple isoforms:\n- **Isoform 1** (canonical): 583 amino acids\n- **Isoform 2**: Alternative N-terminus\n- **Isoform 3**: Truncated variant\n\n## Protein Structure\n\nFOXP1 contains several functional domains:\n\n1. **N-terminal Repression Domain**: Mediates transcriptional repression through interactions with corepressors\n2. **Forkhead Domain**: DNA-binding domain (residues 175-275) that recognizes the consensus sequence TAAACA\n3. **Leucine Zipper Domain**: Mediates protein-protein interactions\n4. **C-terminal Transactivation Domain**: Activates target gene transcription\n\n## Molecular Function\n\n### Transcriptional Regulation\nFOXP1 functions as a transcriptional repressor and activator:\n- **DNA binding**: Forkhead domain binds FOX consensus sequences\n- **Corepressor recruitment**: Interacts with NCoR, SMRT, HDACs\n- **Coactivator interactions**: Partners with CREB, p300\n\n### Target Genes\n## Expression Pattern\n\n### Brain Expression\nFOXP1 is expressed in:\n- **Cerebral [cortex](/brain-regions/cortex)**: Layer 5 pyramidal [neurons](/entities/neurons)\n- **Striatum**: Medium spiny neurons\n- **Basal ganglia**: Motor circuit components\n- **Cerebellum**: Purkinje cells\n- **[Hippocampus](/brain-regions/hippocampus)**: CA1-CA3 regions\n\n### Development\n- Expressed in embryonic brain\n- High expression in motor neuron progenitors\n- Continues in adult brain regions\n\n## Role in Neurodegeneration\n\n### Huntington's Disease\n- FOXP1 expression altered in HD striatum\n- Motor circuit dysfunction involves FOXP1\n- Therapeutic target potential\n\n### Alzheimer's Disease\n- Cognitive function regulation\n- Altered expression in AD brain\n- Synaptic plasticity effects\n\n### Parkinson's Disease\n- Motor circuit regulation\n- Altered in PD models\n- Dopaminergic signaling effects\n\n### Autism Spectrum Disorder\n- FOXP1 mutations cause autosomal dominant ASD\n- Speech and language impairment\n- Intellectual disability\n\n### Speech-Language Disorder\n- FOXP1 is essential for speech production\n- Oral motor function regulation\n- Apraxia of speech\n\n## Disease Associations\n\n## Therapeutic Implications\n\n### Drug Development\n- **FOXP1 modulators**: Enhance or inhibit activity\n- **[HDAC](/entities/hdac-enzymes) inhibitors**: Target FOXP1 repression\n- **Gene therapy**: AAV delivery\n\n### Biomarkers\n- FOXP1 expression as disease progression marker\n\n## Animal Models\n\n### Knockout Mice\n- **Foxp1⁻/⁻ mice**: Embryonic lethal\n- **Foxp1+/- mice**: Motor impairments\n- Altered striatal development\n\n### Transgenic Models\n- Foxp1 overexpression in brain\n- Human mutation knock-in\n\n## Key Publications\n\n1. Bacon C, et al. \"The autism and schizophrenia associated gene FOXP1 is required for perinatal breathing and survival.\" *Respiratory Physiology & Neurobiology*. 2020;276:103400. [PMID:32028028](https://pubmed.ncbi.nlm.nih.gov/32028028/).\n\n2. Fernandez T, et al. \"Disruption of FOXP1 in humans and mice: implications for neurodevelopment and speech.\" *Neuropsychopharmacology*. 2022;47(1):195-206. [PMID:34520504](https://pubmed.ncbi.nlm.nih.gov/34520504/).\n\n3. Aravena I, et al. \"FOXP1 and speech: from gene to circuit.\" *Brain and Language*. 2021;217:104892. [PMID:34029947](https://pubmed.ncbi.nlm.nih.gov/34029947/).\n\n4. Usui N, et al. \"Foxp1 in motor neuron development and disease.\" *Journal of Molecular Neuroscience*. 2023;73(2-3):132-145. [PMID:37188923](https://pubmed.ncbi.nlm.nih.gov/37188923/).\n\n5. Sollis E, et al. \"Identification and functional characterization of FOXP1 mutations in neurodevelopmental disorders.\" *Human Molecular Genetics*. 2023;32(5):831-845. [PMID:36349512](https://pubmed.ncbi.nlm.nih.gov/36349512/).\n\n## Background\n\nThe study of Foxp1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.\n\nHistorical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.\n\n## See Also\n\n- [FOXP1 Protein](/proteins/foxp1-protein)\n- FOXP2 Gene\n- [Transcription Factors](/mechanisms/transcription-regulation-neurodegeneration)\n- [Motor Neurons](/cell-types/motor-neurons)\n- [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder)\n- [Huntington's Disease](/diseases/huntingtons-disease)\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n\n## ",
  "entity_type": "gene"
}